Stay updated with breaking news from Orlucent Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- In a first-in-human study, researchers at Orlucent, Inc. have demonstrated the viability of a novel handheld point-of-care molecular Skin...
/PRNewswire/ -- Researchers evaluating and comparing the gene expression profiles of common (non-malignant) moles and melanoma, the most aggressive skin...
/PRNewswire/ -- Orlucent, Inc., a company focused on clinical assessment of suspicious moles, today announced the U.S. Food and Drug Administration (FDA) has...